These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 881743)

  • 1. A controlled, double-blind study of dl-alpha-tocopheryl nicotinate (Juvela-Nicotinate) for treatment of symptoms in hypertension and cerebral arteriosclerosis.
    Iino K; Abe K; Kariya S; Kimura H; Kusaba T
    Jpn Heart J; 1977 May; 18(3):277-83. PubMed ID: 881743
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative double-blind trial of dl-alpha-tocopheryl nicotinate on vibration disease.
    Matoba T; Kusumoto H; Mizuki Y; Yamada K
    Tohoku J Exp Med; 1977 Sep; 123(1):67-75. PubMed ID: 335571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effect of dentifrice containing dl-alpha-Tocopheryl nicotinate].
    Ikeda K; Hikima T; Kusunoki K; Watanabe Y; Ohara M; Fujihashi H; Shimojima T; Kurihashi Y; Maekawa K; Shimojima T; Kurihashi Y
    Nihon Shishubyo Gakkai Kaishi; 1982 Dec; 24(4):619-32. PubMed ID: 6963312
    [No Abstract]   [Full Text] [Related]  

  • 4. A prevention trial on cerebral infarction with dl-alpha-tocopheryl nicotinate--rationales for trial. The Alpha-Tocopheryl Nicotinate Prevention Study Group.
    Hata Y; Terashi A; Matsuzaki T; Ohtomo E; Goto Y
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():204-7. PubMed ID: 1297741
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with the medical treatment of chronic cerebrovascular insufficiency: bamethan and inositol nicotinate versus placebo].
    Cucinotta D; Silvestrini C; Mancini M; Maini C; Passeri M
    G Clin Med; 1981 May; 62(5):339-50. PubMed ID: 6115790
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic contact dermatitis due to DL-alpha-tocopheryl nicotinate.
    Oshima H; Tsuji K; Oh-I T; Koda M
    Contact Dermatitis; 2003 Mar; 48(3):167-8. PubMed ID: 12755738
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cosaldon in the treatment of cerebral arteriosclerosis].
    Dzialek E; Orzechowska-Wolczyk M; Zawadzki Z
    Wiad Lek; 1975 Sep; 28(18):1547-9. PubMed ID: 1163042
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic action of nicergoline in the treatment of cerebrovascular and peripheral disorders].
    Pasotti C; Liverta C; Cacciatori D; Pollini C
    Farmaco Prat; 1974 Sep; 29(9):508-19. PubMed ID: 4608968
    [No Abstract]   [Full Text] [Related]  

  • 9. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergic contact dermatitis caused by tocopheryl nicotinate.
    Navarro-Triviño FJ; Linares-González L; Ayén-Rodríguez Á; Ruiz-Villaverde R
    Contact Dermatitis; 2021 Jun; 84(6):479-480. PubMed ID: 33400821
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical effects of circuletin-F on peripheral circulation disorders in essential hypertension and cerebral arteriosclerosis -- study by a double-blind method].
    Tahara T; Yoshisaka K
    Horumon To Rinsho; 1975 Mar; 23(3):265-72. PubMed ID: 1102155
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of alpha-tocopheryl nicotinate and acetate on skin microcirculation.
    Kamimura M
    Am J Clin Nutr; 1974 Oct; 27(10):1110-6. PubMed ID: 4417850
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative effects of sodium nicotinate and dihydroergotamine on cerebral circulation. Rheographic studies in subjects with cerebral vascular diseases].
    Arrigo F; Turiano S; Consolo F
    Boll Soc Ital Biol Sper; 1973 Mar; 49(5):292-7. PubMed ID: 4786565
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with alpha-tocopheryl nicotinate.
    Noma A; Maeda S; Okuno M; Abe A; Muto Y
    Atherosclerosis; 1990 Oct; 84(2-3):213-7. PubMed ID: 2149270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation of the effect of vitamins E, A, nicotinic acid and diet No. 10 on several indices of lipid and protein metabolism in patients with arteriosclerosis].
    Dovgiallo GKh; Kulago GV; Mironchik IF
    Ter Arkh; 1969 Nov; 41(11):34-8. PubMed ID: 5384744
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical trial of leptazole with nicotinic acid in the management of psycho-geriatric patients.
    Gabrynowicz JW; Dumbrill M
    Med J Aust; 1968 May; 1(19):799-802. PubMed ID: 4872367
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of nicotinic acid on cerebral and peripheral blood supply in attacks (rheoencephalographic and oscillographic studies)].
    Hadjiev D
    Psychiatr Neurol Med Psychol (Leipz); 1965 Aug; 17(8):291-6. PubMed ID: 5847589
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of pyridinocarbamate in chronic cerebral arteriosclerosis].
    de Oliveira JM
    Hospital (Rio J); 1970 Feb; 77(2):441-50. PubMed ID: 4393836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.